You are here: Industry Insights > Pfizer

News List

Pfizer pays BioNTech $120M upfront to form mRNA flu vaccine pact fiercebiotech
August 17, 2018
Pfizer has struck a $425 million deal to work with BioNTech on the development of mRNA influenza vaccines. The Big Pharma is providing $120 million in upfront and near-term payments to enter into the R&D collaboration.
Pfizer alumnus Geno Germano heads up nanoparticle startup Elucida fiercebiotech
August 16, 2018
When Geno Germano left Pfizer in 2016, he headed to the synthetic biology firm Intrexon, but left relatively quickly as a restructuring changed the startup’s focus. Now, the pharma veteran has taken the helm at Elucida Oncology
Pfizer joins DOJ probe into claims pharma bribes funded Iraqi terrorists fiercepharma
August 15, 2018
Pfizer has joined three of its Big Pharma peers in a Department of Justice probe examining allegations that the companies paid bribes to a terrorist-run health ministry in Iraq.
Pfizer's Besponsa, Lilly's Taltz rack up reimbursement wins at NICE fiercepharma
August 13, 2018
A couple of drugmakers are celebrating this week after favorable decisions from England’s cost watchdog.
Pfizer's Innovative drug IBRANCE gets China approval biospectrumasia
August 10, 2018
World's First Kinase 4/6 (CDK 4/6) Inhibitor and Only Innovative Breakthrough Therapy for Advanced Breast Cancer in China over Past Ten Years
NICE changes its mind on Pfizer’s Besponsa pharmatimes
August 10, 2018
NICE has reversed its draft decision rejecting Pfizer’s Besponsa (inotuzumab ozogamicin) as a treatment for adults with a certain form of leukaemia, meaning the drug will now be available on the NHS in England and Wales.
Pfizer to stockpile medicines in preperation for no-deal Brexit pharmafile
August 07, 2018
Pfizer have joined AstraZeneca, Sanofi and MSD in stockpiling medicines in preparation for a hard Brexit.
Pfizer contracts with Antares to build a rescue auto-injector for an unnamed drug fiercebiotech
August 07, 2018
Pfizer has tapped Antares Pharma for the development of a self-administered combination drug-device rescue pen for an undisclosed medicine, shortly after investing $465 million in a new sterile injectables plant.
Pfizer’s Xeljanz secures marketing authorisation in Europe pharmaceutical-technology
August 06, 2018
Pfizer has received approval from the European Commission (EC) to market Xeljanz (tofacitinib citrate) for the treatment of adults suffering from severely active ulcerative colitis (UC).
Pfizer announces EC approval of its oncology biosimilar biospectrumasia
August 06, 2018
The European Commission decision marks the approval of Pfizer’s first therapeutic oncology bio-similar.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page